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Abstract
Background: A rapid, sensitive and accurate laboratory diagnosis is of prime importance in suspected extrapulmonary
tuberculosis (EPTB) cases. However, traditional techniques for the detection of acid-fast bacilli have limitations. The aim
of the study was to evaluate the diagnostic value of immunocytochemical staining for detection of Mycobacterium
tuberculosis complex specific antigen, MPT64, in aspirates from pleural effusions and lymph nodes, the most common
presentations of EPTB.
Method: A cross-sectional study was conducted by including patients at Tikur Anbessa Specialized Hospital and the
United Vision Medical Services from December 2011 to June 2012. Lymph node aspirates and pleural fluid samples
were collected and analyzed from a total of 51 cases (26 tuberculous (TB) pleuritis and 25 TB lymphadenitis) and 67
non-TB controls. Each specimen was subjected to Ziehl-Neelsen (ZN) staining, culture on Lowenstein– Jensen (LJ)
medium, cytological examination, Polymerase Chain Reaction (PCR) using IS1081gene sequence as a primer and
immunocytochemistry (ICC) with polyclonal anti-MPT64 antibody. All patients were screened for HIV.
Result: ICC was positive in 38 of 51 cases and in the 7 of 67 controls giving an overall sensitivity and specificity
of 74.5% and 89.5%, respectively. Using IS1081-PCR as a reference method, the sensitivity and specificity, positive
and negative predictive value of ICC was 88.1%, 89.5%, 82.2% and 93.2%, respectively. The case detection rate
increased from 13.7% by ZN stain to 19.6% by LJ culture, to 66.7% by cytology and 74.5% by ICC.
Conclusion: Immunocytochemistry with anti-MPT64 antigen improved detection of TB in pleural effusion and lymph
node aspirates. Further studies using monoclonal antibodies on samples from other sites of EPTB is recommended to
validate this relatively simple diagnostic method for EPTB.
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Background
Tuberculosis (TB) is an important public health problem
in Ethiopia. According to World Health Organization
(WHO) report of 2011, the estimated prevalence of TB
cases in Ethiopia in 2010 was 394 per 100,000 and
Ethiopia rank eighth among the 22 high TB- burden
countries [1].
Mycobacterium tuberculosis (M. tuberculosis) has the
ability to colonize almost any site in the body and it can
affect organs other than the lung such as; pleura, lymph
nodes, abdomen, genitourinary tract, skin, joints, bones
and meninges [2,3].
According to the TB and leprosy control program of
Ethiopia, in the year 2010/2011, pulmonary TB accounts
for 67.5% and extrapulmonary tuberculosis (EPTB) for
32.5% of all the new TB cases [4]. The most prevalent
type of EPTB is tuberculous lymphadenitis (TBLN) [5,6]
with tuberculous pleuritis (TBP) being the second most
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frequent extrapulmonary manifestation [7,8]. In spite of
these high numbers, the diagnosis of EPTB remains a
challenge for both clinicians and microbiologists [9,10],
because the disease presents in different ways and lack
of diagnostic resources in developing countries adds to
the problem. Diagnosis of EPTB is difficult due to its
paucibacillary nature and the irregular distribution of
bacilli that tend to clump together resulting in very low
sensitivity of conventional acid fast bacilli (AFB) smear
and culture [11,12].
A recent study has examined the performance of an im-
munocytochemical (ICC) staining method for the detec-
tion of M. tuberculosis complex specific antigen; MPT64
in the diagnosis of EPTB. In this study ICC showed an
overall sensitivity of 67.4% and a specificity of 95% [13].
MPT64 is a 26-kd secreted protein produced by M. tuber-
culosis complex organisms, and this antigen has not been
detected in non-tuberculous mycobacteria. But, this anti-
gen is absent in BCG strains with RD2 deletion [14].
The aim of our study was to evaluate the diagnostic abil-
ity of ICC staining to diagnose TBLN and TBP by the
detection of M. tuberculosis complex specific antigen,
MPT64 in a patient population from Ethiopia and com-
pare the results with conventional methods i.e. Ziehl-
Neelsen (ZN) staining and Lowenstein– Jensen (LJ)
culture and polymerase chain reaction (PCR).
Methods
Study design, participants and specimens
Patients were included in the study from Tikur Anbessa
Specialized Hospital and the United Vision Medical Ser-
vices, Addis Ababa, Ethiopia from December 2011 to June
2012 by employing a cross-sectional study design. Pleural
fluid specimens were collected consecutively from inpa-
tients with a clinical diagnosis of TBP (n = 26), parapneu-
monic effusion (n = 14), pleural effusion secondary to
malignancy (n = 7), cardiac failure (n = 6), cirrhosis (n = 5),
chronic kidney disease (n = 5). Whereas lymph node aspi-
rates were collected from ambulatory patients who were
consecutively referred to United Vision Medical Services
for fine needle aspiration cytology (FNAC) with a diagno-
sis of TBLN (n = 25), lymphadenopathy secondary to
reactive condition other than TB (n = 19) and Hodgkin’s
lymphoma (n = 11). Patients with active pulmonary TB
on chest x-ray, patients receiving antituberculosis treat-
ment prior to fine needle aspiration (FNA) or to thora-
cocentesis, and patients with contraindications to
thoracocentesis were not included in the study.
A detailed clinical history (including sign and symp-
toms like, cough, fever and weight loss), physical exam-
ination, hemogram, tests for HIV, and chest X-ray were
conducted for each study participant. The collected
specimens were processed for ZN staining, culture on LJ
medium and cytological examination. Deoxy ribonucleic
acid (DNA) was extracted from pleural fluid and lymph
node aspirates and PCR was performed using primers
specific for IS1081. Immunocytochemical staining was
performed with anti-MPT64 polyclonal antibody on
smears from the sediment of pleural fluid and fine nee-
dle aspirate of the enlarged lymph node.
Patients were considered as cases when there was a
clinical suspicion of TBLN or TBP and with a laboratory
confirmation with either of the following tests, acid fast
bacilli on ZN stain, and/or positive mycobacterial culture
on LJ medium and/or positive by IS1081 based PCR
and/or suggestive cytological finding of TB on Wright
stained smear. Controls for the current study were pa-
tients with a clinical diagnosis other than TB and the ab-
sence of TB is confirmed by the above mentioned
laboratory tests.
Ethical consideration
Informed consent was obtained from each study partici-
pant and confidentiality was ensured. The decision to do
a thoracocentesis or fine needle aspiration was made on
clinical ground and not for the sake of participation in
this study. Ethical approval was obtained from the de-
partmental research ethical review committee of the de-
partment of Medical Laboratory Sciences, Addis Ababa
University, Armauer Hansen Research Institute (AHRI)
and All Africa Leprosy, Tuberculosis and Rehabilitation
Training Centre (ALERT) Ethics Review Committee
and the National Research Ethics Review Committee of
Ethiopia.
Fluids and aspirates
Consecutive pleural fluid samples (5–8 ml), aseptically
aspirated, were collected in falcon tubes containing hep-
arin (2 mg/ml) and sent to Microbiology department of
Tikur Anbessa Specialized Hospital for microbiological
analysis. Fine needle aspiration was performed from
palpable lymph nodes of suspected cases by an experi-
enced pathologist as an outpatient procedure using 21
Gauge needle attached to 10 ml syringe following stand-
ard procedure. One half of the fluid and aspirate sample
was used for culture and DNA extraction. The other half
was used for preparation of three smears; one was fixed
for cytological examination, the second half for ZN stain
and the remaining smear for ICC staining. The slide for
ICC was fixed with absolute alcohol, covered with
aluminum foil and stored at −20°C till processed.
ZN stain and mycobacterial culture
Standard ZN staining procedure was applied with Clin-
Tech Ziehl-Neelsen staining method kit (Clin-Tech Ltd,
Unit G Perram Woks, United Kingdom). Three tubes of
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LJ medium (Fluka Analytical, Sigma-Aldrich, Switzerland)
(two tubes with glycerol and one with sodium pyruvate)
were used for inoculation and samples were incubated at
35 ± 2°C. The inoculated tubes were examined up to
8 weeks and colonies grown on LJ medium were con-
firmed by ZN staining.
To ensure the quality of ZN staining the following
quality control measures were taken. A positive (M. tu-
berculosis) and a negative (mixed non acid fast organ-
isms) control sputum smears were stained each time an
acid fast stain was performed, if the controls did not
show the proper reaction, patient and control sample
were re-stained. Besides this, the entire positive and 10%
of the negative slides were re-read by experienced la-
boratory technicians.
As a quality control measure for LJ culture, sterility
and performance testing was done. Sterility testing was
carried out by taking 3–5% of each batch and incubated
at 35°C for 2 days, the rest was kept refrigerated. If more
than two colonies per tube are seen, the whole batch of
the LJ media was discarded. Performance testing for LJ
media was done by streaking the stock strains of Myco-
bacterium gordonae (fast grower mycobacterium) on LJ
tube. Overnight incubation was then done at 37°c and
the good quality of LJ medium was assured by growth
seen after an overnight incubation.
Cytological examination
Cytological examination of lymph node aspirates and
pleural fluids was done by staining with Wright solution
and the examination was done by an experienced path-
ologist. Aspirates from lymph nodes were diagnosed as
TBLN based on the presence of granulomas consisting
of epithelioid cells/giant cells without caseation necrosis
(Group I), necrotizing granulomas having variable de-
gree of necrosis with scattered well-formed granulomas
(Group II) and largely necrotic material with neutro-
phils, lymphocyte and a few scattered epithelioid cells
(Group III).
TBP was diagnosed by cytological findings of lympho-
cytic pleural effusion in a proteinaceous or fluidy back-
ground, devoid of neoplastic cells.
Polymerase chain reaction assay
DNA extraction from lymph node aspirate and pleural fluid
Genomic DNA extraction was performed as previously
described by Arora et al. and Pahwa et al. [15,16]. Briefly,
400 μl of the FNA material was incubated in water bath at
80°C for 30 minutes and then diluted with 500 μl of Tris-
EDTA (TE) buffer (10 mM Tris, 1 mM EDTA, pH 8.0).
Similarly, 400 μl of pellet from a centrifuged pleural fluid
sample was resuspended in 500 μl of TE buffer. The bac-
teria were then lysed with 50 μl lysozyme (10 mg/ml)
(Sigma-Aldrich, Chemie Gmbh, Steinheim, Germany) and
incubated for 1 hour at 37°C for lymph node aspirate and
2 hours for pleural fluid.
The lysozyme-treated samples were incubated at 65°C
for 10 minutes and 1 hour in the presence of 5 and 6 μl
of 10 mg/ml of proteinase K (BDH Biochemical, VWR
International LTD, England) for lymph node and pleural
fluid sample respectively in the presence of 70 μl of 10%
sodium dodecylsulphate (SDS). A 100 μl of 5 M solution
of sodium chloride and subsequently a 100 μl pre-warmed
cetyltrimethyl ammonium bromide (CTAB)/sodium chlor-
ide solution were added before incubating in water bath at
65°C for 10 minutes. Then phenol/chloroform/isoamyl al-
cohol (25:24:1) extraction was performed. The DNA pre-
cipitate was obtained by adding absolute alcohol after
overnight incubation at −20°C and the DNA was pelleted
by centrifugation at 12,000 rpm for 15 minutes, then
washed with cold 70% ethanol, and resuspended in 30 μl
of TE buffer. The concentration of the extracted DNA was
approximated by running it on a 1% agarose gel electro-
phoresis. Finally, the DNA samples were stored at −20°C
until used for PCR.
The quality of the DNA extraction protocol was first
assured by running known samples of pleural fluid and
lymph node aspirate which contain mycobacterial DNA.
A positive sample and a negative control, i.e. TE buffer
in place of sample were run in each batch of DNA
extraction.
Polymerase chain reaction
PCR was performed using IS-1081 (an insertion se-
quence element which is found in multiple copies of five
to seven) within the chromosome of all strains belonging
to M. tuberculosis complex) primers (forward and re-
verse), Hot StartTaq Master Mix (Qiagen, Germantown,
MD, USA) and QiagenRNase-Free Water (Germantown,
MD, USA). A total of 25 μl, PCR reaction mix contain-
ing 4 μl of the extracted DNA, 10 μl of HotStarTaq mas-
ter mix, 0.5 μl of each forward and reverse primers and
5 μl of RNase-Free water was used for PCR amplifica-
tion. The PCR amplification was carried out for 35 cy-
cles, where each cycle was 95°C for 1 minute, 55°C for
30 seconds, and 72°C for 30 seconds with an initial heat
activation step of 95°C for 15 minutes and a final exten-
sion of 72°C for 10 minutes using TC 512 Thermocycler
(Barworld Scientific, England). The amplified product
was analyzed in a 2% agarose gel containing ethidium
bromide (Fisher Bioreagents, Fair Lawn, USA). Positive
samples showed a band at 136 base pair and pictures of
the gels were taken after exposing to UV light for
documentation.
PCR-positive and PCR-negative controls were proc-
essed in all PCR assays. Three types of PCR positive
controls were included: (i) M. tuberculosis strain H37Rv
DNA, (ii) known ZN positive and culture-positive test
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sample and (iii) positive sample from previous PCR run.
Similarly, three types of PCR-negative controls were also
processed in each set of assays: (i) an extraction con-
trol (with all the steps but without any extracted ma-
terial), (ii) a reaction tube with substitution of Qiagen
RNase free-water for the test template (iii) a negative
sample from previous PCR assay. To check for cross-
contamination, random samples were retested. Separ-
ate laboratory spaces which were dedicated to the
process of DNA extraction, PCR mixture preparation,
cycling and electrophoresis were used.
Immunocytochemical staining
Immunocytochemical staining was performed according
to Purohit et al. [13]. Briefly, ICC staining was done with
DakoCytomation kit (EnVision + System-HRP; DakoCyto-
mation Denmark A/S, Glostrup, Denmark) on all smeared
fluid and aspirate samples to demonstrate the presence
of MPT64 M. tuberculosis complex specific antigen.
The alcohol-fixed smears were hydrated through de-
creasing grades of alcohol, washed in phosphate buff-
ered saline (PBS) for 10 min, and treated with 3% H2O2
for 15 minutes and then incubated with in-house absorbed
polyclonal anti-MPT64 antibody (received from the
University of Bergen, Norway) at 1/250 dilution. Subse-
quent incubations were then performed with anti-rabbit
dextran polymer conjugated to horseradish peroxidase
and with the substrate consisting of 3-amino-9-ethylcarba-
zol (AEC) and hydrogen peroxide to visualize bound anti-
bodies. Finally, the background was counterstained with
Mayer’s hematoxylin, and the slides were mounted in
Dako Faramount aqueous immunomount for microscopy.
All incubations were carried out at room temperature,
and the slides were washed for 3 minutes three times with
0.05 M tris-buffered saline-tween 20 between incubations.
Mycobacterium antigen was stained reddish brown within
the cytoplasm of macrophages or extracellularly in nec-
rotic materials. Pattern of the intracellular staining might
be granular or diffuse (Figure 1).
In each staining batch, one positive control and two
negative controls were included. The positive control
contains known sample containing M. tuberculosis. In one
negative control, the primary antibody was substituted
with antibody diluent and in the other negative control an
irrelevant rabbit polyclonal antibody (anti- human chorio-
nogonadotrophin) was used to evaluate the specificity of
the reaction.
Statistical analysis
Double entry of data was done using Microsoft Excel 2007
and analysis was done using SPSS Version 20. GraphPad
Prism 5 was also used to construct figures. The perform-
ance indices (the sensitivity, specificity, positive and nega-
tive predictive values, false positive and false negative
rates) of all the modalities was calculated and compared
between cases and controls. The performance indices are
calculated using combination of tests as well as IS1081-
PCR as a reference method. Pearsons Chi-square test and
Fisher’s exact tests were used to compare differences of
categorical variables and the significance was set at a
P value of <0.05.
Results
A total of 118 samples (63 pleural fluid and 55 lymph
node aspirates) were collected from patients attending
Tikur Anbessa Specialized Hospital and United Vision
Medical Service from December 2011 to June 2012. Of
the total study participants, 51 were TB cases (26 cases
of TBP and 25 cases of TBLN) and 67 were controls (37
were pleural fluid and 30 were lymph node aspirates).
Clinical data
In our study, participants from all age groups were in-
cluded ranging from 3 to 85 years with a median age of
35 years. Majority [52/118; (44.1%)] of the study partici-
pants were between 25 to 44 years. Male study partici-
pants constitute 53.4% (63/118) of the total sample and
females constitutes 46.6%. Twenty seven point five per-
cent (14/51) of TB cases and 19.4% (13/67) of non-TB
controls were HIV seropositive.
All patients presented with signs and symptoms ac-
cording to the site of the diseases. The predominating
local symptom for TBP cases was cough, chest pain, loss
of weight and night sweating. While, the predominating
Figure 1 Immunocytochemical staining of lymph node aspirates (A), pleural fluid (B) and negative lymph node aspirate sample (C).
Positive staining is seen as reddish brown within cells and extracellular in necrotic areas as indicated by the arrow in A and B. Pattern of the stained
positive cells may be granular or diffuse.
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local symptom in study participants with TBLN was
neck mass, night sweating, loss of appetite and headache
(Table 1). From a total of 55 participants with lymph-
adenopathy, the majority 43 (78.2%) of them had cervical
lymph node swelling followed by axillary 7 (12.7%) and
submandibular 5 (9.1%) lymph nodes.
Microbiological analysis
As shown in Table 2, ZN staining was positive in 7/51
(13.7%) TB cases and 10/51 (19.6%) of the samples dem-
onstrated growth on LJ media. The bacilli load of the posi-
tive pleural fluid sample was 3 bacilli/100 fields. Unlike
that of pleural fluid samples, AFB was seen in 6/26 (24%)
of lymph node aspirates from cases of TBLN. Out of the 6
ZN staining positive lymph node aspirates, 1+, 2+ and 4
bacilli/100 fields was seen in 3(50%), 2(33.3%) and 1
(16.7%) lymph node aspirates respectively as graded by
WHO/International Union against Tuberculosis and Lung
Disease (WHO/IUATLD). Among the 10 culture positive
samples, 5 (50%) grew on glycerol containing media, 3
(30%) on both glycerol and sodium pyruvate containing
media and the remaining 2 (20%) grew on sodium
pyruvate.
Cytological examination
Cytological examination of pleural fluids and lymph
node aspirates revealed that 16/26 (61.5%) and 18/25
(72.0%) of TBP and TBLN cases were diagnosed as sug-
gestive of TB respectively (Table 2). Forty four percent
(11/25) of TBLN smears showed group I cytomorphologic
change, while group II and III cytomorphologic change
was observed in 8/25 (32%) and 6/25 (24%) of the lymph
node aspirates. As it is described in Table 3, higher per-
centage of positivity of AFB, LJ culture, PCR and ICC was
observed in group II (granuloma with necrosis) cytomor-
phologic pattern compared to the others.
Polymerase chain reaction
Out of 51cases of TB, 42 (82.4%) of the study partici-
pants were positive by IS1081-PCR. Among cases with
TBP and TBLN, 21 (80.8%) and 21 (84.0%) were positive
by IS1081-PCR respectively (Table 2). Figure 2 depicts a
representative gel showing a positive (136 bp) and nega-
tive pleural fluid and lymph node aspirate.
Immunocytochemical staining
Of 51 cases of tuberculous pleuritis and tuberculous
lymphadenitis, ICC staining with anti-MPT64 was positive
Table 2 Laboratory results of different diagnostic procedures in tuberculous pleuritis and tuberculous lymphadenitis
cases and non-TB controls
Diagnosis ZN
stain
Number of specimens n(%) positive by
LJ culture Cytology IS1081-PCR ICC
TB (51)
Pleural fluid (n = 26) 1(3.8) 3(11.0) 16(61.5) 21(80.8) 18(69.2)
Lymph node aspirate (n = 25) 6(24.0) 7(28.0) 18(72.0) 21(84.0) 20(80.0)
Total 7(13.7) 10(1.6) 34(66.7) 42(82.4) 38(74.5)
Non TB (N = 67)
Pleural fluid (n = 37) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 5(13.5)
Lymph node aspirate (n = 30) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 2(6.7)
Total 0(0.0) 0(0.0) 0(0.0) 0(0.0) 7(10.4)
Table 1 Signs and symptoms of study participants by type of extrapulmonary pulmonary tuberculosis
Sign and symptom Pleural fluid (N = 63) Lymph node aspirate (N = 55)
Cases (n = 26) Controls (n = 37) Cases (n = 25) Controls (n = 30)
Neck mass 0(0%) 0(0%) 23(92.0%) 28(93.3%)
Headache 16(61.5%) 6(16.2%) 18(72.0%) 26(86.7%)
Chest pain 23(88.5%) 21(56.8%) 4(16.0%) 2(6.7%)
Cough 24(92.3%) 23(62.2%) 6(24.0%) 3(10.0%)
Fever 17(65.4%) 16(43.2%) 15(60.0%) 9(30.0%)
Tiredness 6(23.1%) 14(37.8%) 15(60.0%) 19(63.6%)
Loss of weight 21(80.8%) 23(62.2%) 16(64.0%) 23(76.7%)
Loss of appetite 23(88.5%) 18(48.6%) 18(72.0%) 17(56.7%)
Night sweating 19(73.1%) 13(35.1%) 18(72.0%) 12(40.0%)
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in 38 of smears and 7 controls, giving the overall sensitiv-
ity, specificity, positive predictive value and negative pre-
dictive value of 74.5, 89.5, 84.4 and 82.2%, respectively. All
ZN and culture positive tuberculous smears were positive
with ICC using anti-MPT64 antibody.
Comparison of diagnostic procedure among cases
The positivity of ZN, LJ culture, cytologic examination,
IS1081-PCR and ICC staining with anti-MPT64 antibody
among 51 cases of TBP and TBLN, as defined by the com-
bination of tests, was compared. As it is shown in Figure 3,
the diagnosis of TB has increased from 7 (13.7%) samples
by ZN stain to 10 (19.6%) by LJ culture. The case detec-
tion further increased to 34 (66.7%) by cytological examin-
ation and to 42 (82.4%) with IS1081-PCR. ICC alone
detected 38 (74.5%) cases. From Figure 3, it is clear that
ICC could detect significantly more cases of TB when
compared to the conventional AFB, culture and cyto-
logical examination.
Diagnostic evaluation of immunocytochemistry
ICC was positive among 38 tuberculous cases and 7 con-
trols, giving an overall sensitivity and specificity of 74.5%
and 89.5%, respectively. Diagnostic validity of ICC was
performed using PCR as a reference method. The sensitiv-
ity, specificity, positive and negative predictive value of
ICC among cases was 88.1%, 89.5%, 82.2% and 93.2%, re-
spectively. The diagnostic parameters are higher among
cases with TBLN than TBP (Table 4).
Positivity of different laboratory tests by HIV serostatus
There was no statistically significant difference with the
positivity of ZN staining, LJ culture, cytology and IS1081-
PCR tests among participants with reactive and non react-
ive HIV serostatus (Table 5). But, a statistically significant
higher number of HIV negative cases were positive with
immunocytochemical staining as compared to the HIV
positive cases (p-value = 0.013).
Discussion
The present study aimed to investigate the diagnostic
value of ICC to detect M. tuberculosis specific antigen,
MPT64, for the diagnosis of the most common presen-
tations of EPTB, TBLN and TBP in pleural fluid and
lymph node aspirate samples from Tikur Anbessa Spe-
cialized Hospital and United Vision Medical Services,
Addis Ababa, Ethiopia. The results showed that ICC
using MPT64 antigen is a sensitive and specific test for
diagnosis of TBLN and TBP. This study confirms the
previous study done on patients from India showing
that ICC using polyclonal anti-MPT64 antibody can be
used to achieve a rapid and early diagnosis of TBLN,
TBP and TB meningitis [13].
The results of this study indicated that only 1/26 (3.8%)
of pleural fluid sample from study participants with TBP
was positive for AFB and the bacillary load of the positive
smear was 3 bacilli/100 microscopic fields. This finding is
in line with other studies, which demonstrated no bacilli
[13,17-19] or found lower detection rates like 0.9% positiv-
ity rate of AFB in Myanmar [20], and 3.8% positivity rate
of AFB was observed in other study [21]. The low positiv-
ity of pleural fluid for ZN staining is attributed to the
Figure 2 IS1081-PCR of DNA extracted directly from pleural fluid and lymph node aspirate of lane 1 represents a 100 bp DNA ladder
(molecular marker), Lane 2 through lane 4 are DNA extracted from pleural fluid, Lane 5 and lane 6 are DNA extracted samples from
lymph node aspirates, Lane 7 thorough 9 represent an amplification product of the positive controls, i.e. M. tuberculosis strain H37Rv
DNA, known ZN-positive and culture-positive test sample, and positive sample from previous PCR run which showed positive result,
Lane 10 through 12, i.e. an extraction control, a reaction with substitution of Qiagen RNase free-water for the test template, and a
negative sample from previous PCR assay gave a negative result.
Table 3 The positivity of different laboratory tests among
various cytomorphologic patterns from lymph node
aspirates of cases with tuberculous lymphadenitis
Cytomorphologic pattern (n = 25)
Non necrotic
granuloma
(n = 11) n (%)
Necrotic
granuloma
(n = 8) n (%)
Necrotic material
(n = 6) n (%)
Laboratory tests
AFB 1(9) 3(38) 2(33)
LJ culture 2(18) 4(50) 1(17)
PCR 9(82) 7(88) 5(83)
ICC 9(82%) 6(75) 5(83)
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pathophysiology of tuberculous pleural effusion, in that
the basic mechanism of TBP is immunologic, i.e. fluid col-
lects as a result of a delayed hypersensitivity reaction to
tuberculous proteins [22].
Unlike that of the pleural fluid sample, 24% of cases of
TBLN were positive for AFB and a similar percentage of
AFB positivity was observed in a study by Aljafari et al.
[23]. The positivity of pleural fluid on LJ culture was
11.5% and this finding is in agreement with other stud-
ies, 15.4% [19], 19% [13]. This may reflect the paucibacil-
lary status of pleural fluid which results at least partly
from immunologic mechanism. The other possible rea-
son for low sensitivity of LJ culture on pleural fluid
might be associated with the small volume of sample.
Besides its low sensitivity, mycobacterial culture requires
biosafety level 3 laboratories challenging the implemen-
tation in resource poor settings. However, the possibility
of drug sensitivity testing by culture makes it an import-
ant and irreplaceable diagnostic tool. Lack of this possi-
bility by ICC is a weakness of this method.
The positivity rate of culture among TBLN cases in
our study was 28% and is comparable with other studies
which revealed 24.4% [24] LJ culture positivity of lymph
node aspirates. But it was lower than the sensitivity of LJ
culture of lymph node aspirates in another study which
has reported a culture positivity of 38.8% [25]. The low
sensitivity in our study might be explained by stage of
the lymphadenitis, where high number of tubercle bacilli
is present in central abscess/ necrotic material [26].
Among cases with TBLN, a higher positivity of AFB, LJ
culture, IS1081-PCR was observed in group II (necrotizing
granulomas) cytomorphologic pattern and this finding
was consistent with other studies showing higher degree
(75.6%) of positivity of AFB [27], culture (26%) among
cases with cytomorphological pattern of necrotizing
granulomas [13]. But, a slightly higher positivity was
observed with ICC in cases with non necrotizing cyto-
morphologic pattern (Table 3), which is consistent with
the previous study by Purohit et al. This implies that
ICC has a great role in the diagnosis of the most diffi-
cult cytomorphologic pattern.
IS1081-PCR was positive among 42/51 (82.4%) cases
of TBP and TBLN and it was positive in 21/26 (80.8%)
of TBP cases and this result agrees with a study con-
ducted to evaluate the performance of IS1081on TBP
which showed a sensitivity of 84.6% [21]. IS1081-PCR
had increased the sensitivity of detection of cases of TB
both in TBP and TBLN. As it was depicted in Figure 3,
IS1081-PCR has increased the case detection of TB in
TBP and TBLN in comparison to LJ culture. PCR posi-
tivity of several cases that were culture negative indicates
that PCR is very sensitive and useful in picking up cases
that may harbor dead bacilli [16].
Using PCR as the gold standard and the sensitivity,
specificity, positive predictive value and negative predict-
ive value were 88.1, 89.5, 82.2 and 93.2%, respectively.
This finding was lower compared to a similar study which
was conducted in India in 2006, where the reported sensi-
tivity and specificity, positive predictive value and negative
predictive value were 96, 96, 95 and 97%, respectively. The
Table 4 Diagnostic evaluation of immunocytochemistry
for pleural fluid and lymph node aspirate
Type of EPTB Sensitivity (%) Specificity (%) PPV (%) NPV (%)
TBP 81.0 88.2 68 93.5
TBLN 95.2 90.1 74.1 98.5
Total 88.1 89.5 82.2 93.2
Table 5 Positivity of laboratory tests among HIV reactive
and non-reactive study participants
Laboratory tests HIV Seros taus
Reactive
n (%)
Non reactive
n (%)
P-value
ZN staining 2(28.6) 5(71.4) 0.659
LJ Culture 2(20.0) 8(80.0) 0.707
Cytology 11(32.4) 23(67.6) 0.148
IS1081-PCR 12(28.6) 30(71.4) 0.360
ICC 16(35.6) 29(64.4) 0.013
Figure 3 Positivity of laboratory tests among cases.
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difference in performance characteristics may be ex-
plained by the variation in case selection criteria, type of
extrapulmonary samples, the cytomorphologic pattern of
lymph node aspirates, and the primer used for PCR ampli-
fication. As it is illustrated in Table 4, the sensitivity, speci-
ficity, positive predictive value and negative predictive
value of the pleural fluid sample is lower than the lymph
node aspirates. This might be due to the paucibacillary
status of pleural fluid which results from immunologic
mechanism. In this study, pre-treatment of pleural fluid
sample for disruption of the immune complexes, in the
view of antigen retrieval, was not done. This was based on
the experience of the earlier study where pre-treatment (e.
g. microwave treatment) did not improve the sensitivity
[13]. This may be due to alcohol fixation of these samples
which does not lead to cross-linking in a manner which
happens with formalin-fixation of the biopsies, making
antigen retrieval necessary.
There were 7 positive samples by ICC among the non-
TB groups. The possible reason for having a false positive
result might be non-specific staining due to the polyclonal
nature of the antibody used, while the false negative might
be due to sample volume [28], to the degradation of anti-
gens with the length of time in storage [29], and the ab-
sence of MPT64 from some TB strains. Therefore the
decision to treat a patient must always be made after a
total evaluation based on the clinical suspicion, and the re-
sults of other diagnostic tests. Furthermore, study using a
monoclonal anti-MPT64 antibody is recommended. The
increase in TB case detection using ICC observed in this
study may be attributed to the ability of ICC to detect
fragments of antigen rather than the presence of the intact
bacilli which is a prerequisite for ZN staining [30,31]. The
lower yields of ICC staining in pleural fluid as compared
to lymph node aspirate could be due to presence of fewer
bacilli at this site, as supported by lower positivity with
culture. This lower yield of conventional and ICC method
might also be explained by lack of adequate sample vol-
umes due to apportioning of sample for various diagnostic
tests [28].
Conclusion
Immunocytochemical staining method showed an in-
creased sensitivity in the diagnosis of TBP and TBLN
compared with other conventional methods, such as ZN
staining, culture and cytological examination. The use of
ICC for the detection of mycobacterial complex specific
antigen for clinical management should always be inter-
preted together with clinical history, examination, and
other diagnostic tests since it does have false positive re-
sults. Furthermore, ICC needs to be evaluated by the
monoclonal anti-MPT64 antibody, with larger number
of sample from other types of EPTB. Otherwise, it is a
simple method which does not require a sophisticated
instrumentation, i.e. it requires an ordinary light micro-
scope for examination of the stained preparations. It
takes 3 and half hours, where patients can have the re-
sult within same day of collection. Due to its simplicity,
ICC can be performed in a routine pathology laboratory.
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